DUBLIN, November 19, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/r7x35z/china) has announced the addition of the "China Pharmaceutical Equipment Industry Report, 2012-2015" report to their offering.
Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over the years, with industrial sales showing a rapid growth trend. In line with statistics of the China Association for Pharmaceutical Equipment, in 2011 the pharmaceutical equipment industry of China achieved gross industrial output value of RMB15.84 billion, a year-on-year increase of 23.5%; sales of RMB16.1 billion, up 25.2% year-on-year; total profit of RMB1.818 billion, up 19.3% YoY; and gross margin of the industry rose to 11.3%.
According to the new GMP regulations and the enforcement of pharmaceutical companies, 2011-2012 is a rapid growth period for China pharmaceutical equipment industry; as the certification ends in 2015, industry revenue growth in 2013-2014 will slow down. It is expected that in 2015, sales of China pharmaceutical equipment industry will attain to RMB31.41 billion.
Chinese pharmaceutical equipment enterprises generally adopt the customized business model, with a relatively low industry concentration. In recent years, market share of the top four enterprises (CR4) is maintained at about 25%. In 2011, Shinva Medical in the first position obtained the revenue of RMB2.1061 billion, with market share up to 13.1%.
Key Topics Covered:
1. Overview of Pharmaceutical Equipment Industry
2. Status Quo of China Pharmaceutical Equipment Industry
2.1.3 Asset Utilization
2.1.5 Market Demand
2.2 Market Competition
2.2.1 Industry Concentration
2.2.2 Entry Barriers
2.3 Technical Status and Development Trend
2.3.1 Status Quo and Characteristics
2.3.2 Development Trend
3. Development Environment of China Pharmaceutical Equipment Industry
3.1 Policy Environment
3.1.1 Regulatory System
3.1.2 Industrial Policy
3.2 Upstream and Downstream Industries
3.2.1 Industrial Chain Structure
4. Development Forecast of China Pharmaceutical Equipment Industry
4.1 Market Size
4.1.1 Periodic Analysis
4.1.2 New GMP Transformation Cost Analysis
4.1.3 Market Size Estimates
4.2 Key Market Segments
4.2.1 Sterilization Equipment Market
4.2.2 Drying Equipment Market
4.2.3 Large-volume Infusion Production Line Market
4.3 Development Trends
4.3.1 Rapid Development of Leading Enterprises through M&A
4.3.2 Product Line Development towards Systemization
4.3.3 Import Substitution in High-end Market
5. Key Enterprises
- Beijing Double-crane Pharmaceutical Equipment .
- Harbin Nano Pharmaceutical & Chemical Equipment
- Hualian Pharmaceutical Machinery
- Hunan China Sun
- Jiangsu Saideli Pharmaceutical Machinery Manufacture
- Shanghai Far-East Pharmaceutical Machinery
- Shinva Medical
- Truking Technology
- Wenzhou Yaguang Machinery Manufacturing
For more information visit http://www.researchandmarkets.com/research/r7x35z/china
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved